Immunosuppressive agents | Tenderlake

Immunosuppressive agents

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
14 June 2019
Closing Date:
15 July 2019
Location(s):
ES52 Comunidad Valenciana (ES Spain/ESPAÑA)
Description:
Framework Agreement for the supply of medicines for human use for the treatment of idiopathic pulmonary fibrosis

Framework Agreement for the supply of medicines for human use for the treatment of idiopathic pulmonary fibrosis.


Pirfenidone tablets, capsules 267 mg

Pirfenidone tablets, capsules 267 mg.


Pirfenidone tablets 801 mg

Pirfenidone tablets 801 mg.


Nintedanib capsules 100 mg

Nintedanib capsules 100 mg.


Nintedanib capsules 150 mg

Nintedanib capsules 150 mg.

Download full details as .pdf
The Buyer:
Dirección General de Eficiencia y Régimen Económico
CPV Code(s):
33652000 - Antineoplastic and immunomodulating agents
33652300 - Immunosuppressive agents